Sign inJoin free

Watch / Three stocks for...

The mid-cap momentum

6 Nov 20259:27

The mid-cap momentum

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Key points:

  • Mid-cap equities viewed as optimal for risk-adjusted returns

  • Under-researched nature presents opportunities for active management

  • Life360 (ASX:360), Imdex (ASX:IMD), JB Hi-Fi (ASX:JBH), Iress (ASX:IRE), and Ryman Healthcare (ASX:RYM) identified as notable stocks

  • Extensive fundamental analysis and site visits drive stock selection

Australian mid-cap equities are attracting increased attention, according to Jack Briggs from Ellerston Capital, who identifies this segment as a compelling opportunity for risk-adjusted returns. Briggs contends that mid caps offer proven business models with growth potential, unlike large caps which lack market share gains and excitement, or small caps which often face governance concerns and reliance on external capital. He points to historic outperformance of the Midcap 50 Index over large caps and significant gains against the Small Ordinaries Index.

Briggs highlights the under-researched nature of mid caps as a notable advantage, allowing for deeper analysis and the potential to identify mispriced opportunities. His investment approach at Ellerston Capital involves comprehensive research, including site visits and competitor checks, to develop a differentiated outlook. Key examples in his portfolio include JB Hi-Fi (ASX:JBH), which he regards as a prime candidate following in-store observations, and Life360 (ASX:360), where he sees upside from the recently launched pet tracker and future advertising revenue, underpinned by a large US user base.

Discussing turnaround stories, Briggs singles out Imdex (ASX:IMD) and Iress (ASX:IRE) as stocks identified through cyclical and execution-driven analysis. He also notes Ryman Healthcare (ASX:RYM), recently listed in Australia, as a mixed turnaround play following in-depth research on the ground in New Zealand.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy